道琼斯 39142.23 -1.33%
纳斯达克 16286.45 -0.13%
标普500 5282.70 0.13%
休盘中 04月20日 04:39(美东)

美股交易时间

夏令:21:30-04:00(北京)
冬令:22:30-05:00(北京)
夏令/冬令:9:30-16:00(美东)

最近浏览

朴荷生物科技

NASDAQ:PHH 实时
13.53 0.52 4.00% 2025-04-17 16:00:00
  • 今开:13.70
    昨收:13.01
  • 今日区间:12.96-13.93
    52周区间:0.00-0.00
  • 成交量:41.83万
    成交额:563.87万
  • 市 值:3.57亿
    市盈率:233.68
  • 贝塔系数:
    每股收益:0.0579
盘后 13.54 0.01 0.07% 成交量 1.03万 2025-04-17 20:00

董事会

Xiao Qiu Zhang
Xiao Qiu Zhang is the Chairman & Chief Executive Officer of Park Ha Biological Technology Co. Ltd., which was founded in 2022. Ms. Zhang is also currently serving as an Independent Director at Mingteng International Corp., Inc. and HUHUTECH International Group, Inc. Ms. Zhang previously worked as a Director at TopLinker Co. Ltd. from 2015 to 2016. Ms. Zhang completed their undergraduate degree at Northeast University of Finance & Economics in 2020.
Wang Li
Wang Li is currently the Director at Park Ha Biological Technology Co. Ltd.
Yanan Shan
Yanan Shan is an Independent Director at Park Ha Biological Technology Co. Ltd.
Qi Xiong Sheng
Qi Xiong Sheng is currently an Independent Director at Park Ha Biological Technology Co. Ltd. and a General Manager at Wuxi Yongda Dongfang Automobile Sales Service Co., Ltd.
Xiao Zhong Yu
Xiao Zhong Yu currently works at Park Ha Biological Technology Co. Ltd., as Independent Director from 2024 and Li Bang International Corp., Inc., as Independent Director from 2024. Mr. Yu received his graduate degree in 2002 from Jiangnan University.